I-Cordis, LLC

Baltimore, MD

UEI
D2AUZ7D5DXJ1
CAGE
827Q1
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
312 Overhill Rd, Baltimore, MD 21210, USA
Website
i-cordis.com
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a novel immunomodulatory pyridone for the treatment of heart failure with preserved ejection fraction R44HL145833 National Heart Lung and Blood Institute (NIH) $3,097,416
Development of a novel immunomodulatory pyridone for the treatment of acute heart damage R43HL145833 National Heart Lung and Blood Institute (NIH) $276,227

Quick answers

Is I-Cordis, LLC registered in SAM.gov?

Yes. I-Cordis, LLC's SAM.gov registration is active through July 24, 2027.

What is I-Cordis, LLC's most recent federal award?

I-Cordis, LLC's most recent federal grant award is Development of a novel immunomodulatory pyridone for the treatment of heart failure with preserved ejection fraction (R44HL145833), from National Heart Lung and Blood Institute (NIH), on September 18, 2019.

On GovTribe

See I-Cordis, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login